Missing/wrong data?
Log in to edit
Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study
scientific article published on 23 October 2020
Author/s
author: Adam D Cohen, Sagar Lonial
Work details
Publication date
October 23, 2020
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.